Explore our core OEM/ODM validation modules and phytochemical active-substance discovery pipelines.
ODM Clinic study (Phase1 - Phase 4) Manufacturer, Suppliers
Service Details
China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers
Service Details
China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers
Service Details
ODM Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins. Manufacturer, Suppliers
Service Details
OEM In Vitro Test /Research Service Manufacturers, Suppliers
Service Details
OEM Animal study Supplier, Suppliers
Service Details
Target Molecule & Phytochemical Fraction Screening Platform
Service Details
Evaluation for Natural Materials Origin & Potency Validation
Service DetailsTraditional remedies rely heavily on qualitative folklore. MedGence (Yineng Pharma) bridges this gap by applying metabolomics, HPLC/HPTLC molecular fingerprinting, and quantitative pharmacology to validate Traditional Chinese Medicine (TCM) compounds, providing documented chemical proof for global regulatory approvals.
Under our strict entrusted research protocol, intellectual property remains 100% proprietary to the client. Formula compositions, extraction temperatures, purification ratios, and patent-ready documentation are protected under strict international non-disclosure standards.
We eliminate the traditional friction between discovery laboratories and mass contract manufacturing plants. Validated bench-scale findings transfer directly into our GMP-compliant pilot lines and commercial industrial facilities without intermediate re-formulation delays.
Pharma, nutraceutical, and dermaceutical conglomerates are departing from raw crude powders toward standardized, bio-available botanical drug substances.
Regulatory authorities including the US FDA (Botanical Drug Guidance), EMA (HMPC monographs), and PMDA enforce tighter limits on residual pesticides, heavy metals, aflatoxins, and cross-batch fingerprint deviations. Crude sourcing without validated assays faces immediate customs rejection.
E-commerce consumers and healthcare practitioners reject vague assertions. Buyers require double-blind, placebo-controlled clinical human trial metrics (Phase I–IV) and peer-reviewed in vitro validation to justify premium market positioning and distinct structure/function claims.
Western brands are consolidating multi-tier procurement. Sourcing raw botanicals in Asia, shipping to intermediate processors, and testing in domestic third-party labs inflates lead times by 6–10 months. Direct integration with a China-based CRO/CDMO compresses time-to-market by over 50%.
Combining ecological cultivation clusters, continuous flow extraction, and automated SCADA batch controls to guarantee global supply security.
China hosts over 11,000 medicinal plant species. Our facility leverages verified Daodi origin matrices across Sichuan, Yunnan, Hunan, and Changbai mountain belts, ensuring botanical active concentrations exceed standard industrial baselines.
Low-temperature supercritical extraction and ceramic membrane filtration prevent thermal degradation of heat-sensitive flavonoids, terpenoids, and volatile aromatics, yielding 99%+ pure botanical fractions without toxic residues.
Fully networked SCADA automated extraction suites monitor solvent pressure, evaporation temperatures, and residence time down to milliseconds, maintaining inter-batch chromatographic consistency within a 2.5% delta.
By utilizing biomass co-generation from post-extraction spent herb cakes and recycling 98.5% of process ethanol via multi-effect vacuum recovery, our manufacturing lines minimize both carbon footprint and production overhead.
Enterprise drug candidates, therapeutic formulations, and custom nutraceutical blends backed by comprehensive empirical studies.
Utilizing proprietary chemical libraries, our research teams rapidly isolate bioactive alkaloids, saponins, and polyphenols. We identify specific mechanistic receptors (e.g., AMPK, NF-κB, COX-2) to validate molecular pathway efficacy prior to formulation scale-up.
Phytochemical density fluctuates based on elevation, soil mineral profiles, and harvest periods. We execute multi-harvest chromatography profiles across distinct climates to pinpoint optimal harvesting conditions for client compounds.
Establishment of defensible identity testing via HPTLC, HPLC-DAD, and GC-MS. We formulate comprehensive master testing monographs that withstand stringent multi-agency regulatory audits worldwide.
Full-spectrum safety assessment including acute oral toxicity (LD50), 90-day sub-chronic repeated dose assays, bacterial reverse mutation (Ames test), and mammalian chromosomal aberration studies to establish human safety margins.
Full clinical CRO execution across our network of accredited clinical research hospitals. We facilitate IRB approvals, cohort recruitment, randomized double-blind protocol deployment, and biostatistical analysis for new drug applications.
From micro-encapsulated spray-dried powders and stabilized supercritical oils to high-speed encapsulation, oral liquid bottling, blistered tablets, and enteric coated softgels, we provide total CDMO manufacturing fulfillment.
Adapting botanical chemistry to the strict regulatory regimes and consumption habits of regional consumer markets.
DSHEA-compliant active standardization. Formulated specifically to pass third-party testing protocols (USP, NSF, Informed-Choice) with full absence of undeclared adulterants, microbial contamination, or solvent trace compounds.
Navigating Traditional Herbal Medicinal Products Directive (Directive 2004/24/EC). We provide 30-year medicinal use documentation trails, validated toxicological dossiers, and PAH/residual solvent control compliant with Ph. Eur.
Clean-taste, water-dispersible botanical extracts for nutricosmetics and ready-to-drink functional beverages. Overcoming typical bitter herbal astringency using molecular inclusion and natural enzymatic masking techniques.
Essential validation criteria for Chief Scientific Officers, Procurement Managers, and Quality Assurance Teams.
Select verified clinical, analytical, and manufacturing capabilities to accelerate your product pipeline.
ODM Clinic study (Phase1 - Phase 4) Manufacturer, Suppliers
Service Details
China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers
Service Details
China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers
Service Details
ODM Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins. Manufacturer, Suppliers
Service Details
OEM In Vitro Test /Research Service Manufacturers, Suppliers
Service Details
OEM Animal study Supplier, Suppliers
Service Details
Clinical Study Protocol & Biostatistical Reporting Package
Service Details
Analytical Method Establishing (HPTLC, HPLC, Fingerprinting)
Service Details